Target intelligence / Profile preview

Vaginal mucin (MUC)

Target
MUC
Molecular classification
Glycoprotein, Mucin family
01

Overview

Vaginal mucins are high-molecular-weight glycoproteins, primarily MUC1, MUC4, MUC5B, and MUC16, that form the structural framework of the cervicovaginal mucus (CVM) (PubMed: 15707447). These proteins are characterized by extensive O-glycosylation, which allows them to retain water and provide essential lubrication and barrier functions against pathogens and mechanical friction (NCBI: NBK542186). In therapeutic applications, these glycoproteins act as the primary docking site for mucoadhesive polymers such as polycarbophil. Polycarbophil, a high-molecular-weight polymer of acrylic acid, interacts with the mucin layer through hydrogen bonding between its carboxylic acid groups and the sugar residues of the mucins, as well as through physical chain entanglement (PubChem: CID 6850774). This interaction facilitates the prolonged residence time of drugs, such as progesterone or dinoprostone, and helps maintain vaginal hydration in conditions like atrophic vaginitis (StatPearls: NBK559283). By adhering to the mucus layer, these polymers provide a sustained release platform for local treatments while simultaneously acting as a humectant to alleviate symptoms of dryness.

Other names
Vaginal mucus glycoproteinsCervicovaginal mucinsMUC1MUC4MUC5BMUC16Vaginal mucous layer glycoproteins
02

Mechanism of action

Mucoadhesion through hydrogen bonding and physical chain entanglement between polymer chains (e.g., polycarbophil) and the oligosaccharide side chains of mucin glycoproteins.

03

Biological functions

Physical barrierLubricationPathogen entrapmentHydration of the vaginal epithelium
04

Disease associations

Atrophic vaginitisVaginal drynessBacterial vaginosisInfection prevention (HIV/STI)
05

Safety considerations

Local irritationVaginal dischargePotential disruption of the natural vaginal microbiome
06

Interacting drugs

Polycarbophil

4 more in the full profile.

07

Biomarkers

Vaginal pHMucus viscosityMucin expression levels

Beyond the preview

Go deeper on Vaginal mucin (MUC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal mucin (MUC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call